Is smoking a prognostic factor in patients with chronic hepatitis C?

Minerva Gastroenterologica e Dietologica

Volumn 55, Issue 2, 2009, Pages 139-143

  De Luca, L ^a   De Angelis, C ^b   Fagoonee, S ^c   Di Bella, S ^a   Rizzetto, M ^b   Pellicano, R ^b  

^a Pellegrini Hospital   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Fibrosis; Hepatitis C; Liver cirrhosis; Smoking

Indexed keywords

ALANINE AMINOTRANSFERASE; NICOTINE; VASCULOTROPIN; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; CYTOKINE; PROTEIN TYROSINE KINASE; VASCULOTROPIN A;

CIGARETTE SMOKING; CYTOKINE PRODUCTION; FATTY LIVER; FIBROGENESIS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HYPOXIA; LIPID PEROXIDATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER METABOLISM; LIVER NECROSIS; OXIDATIVE STRESS; PROGNOSIS; REVIEW; RISK FACTOR; TOBACCO; ANIMAL; ANOXIA; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DRUG EFFECT; EVIDENCE BASED MEDICINE; HOSPITALIZATION; METABOLISM; PATHOLOGY; SMOKING;

ANIMALS; ANOXIA; CYTOKINES; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; HEPATITIS C, CHRONIC; HUMANS; LIPID PEROXIDATION; LIVER CIRRHOSIS; OXIDATIVE STRESS; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 68149089775     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Poynard T, Bedossa P, Opolon P for the OBSVIRC, METAVIR; CLINIVIR and DOSVIR groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32. (Pubitemid 27129209)
2. Castera L. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C. Minerva Gastroenterol Dietol 2006,52:125-34. (Pubitemid 43774322)
3. Pinzani M. Liver fibrosis. Springer Semin Immunopathol 2000;21:475-90. (Pubitemid 30433753)
4. Missiha SB, Ostrowski M, Heathcote EJ. Disease progression in chronic hepatitis C: modifiable and non-modifiable factors. Gastroenterology 2008;134:1699-714. (Pubitemid 351615412)
5. Wiese M, Berr F, Lafrenz M, Porst H, Oesen U for the East German Hepatitis C Study Group. Low frequency of cirrhosis in a hepatitis C (genotype lb) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000;32:91-6. (Pubitemid 30432371)
6. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
7. Hézode C, Lonjon I, Roudot-Thoraval F, Mavier J-P, Pawlotsky J-M, Zafrani ES et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 2003;52:126-9. (Pubitemid 36020778)
8. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001;34:121-5. (Pubitemid 32591491)
9. Wang CS, Wang ST, Chang TT, Yao WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med 2002;162:811-5. (Pubitemid 34273305)
10. Daryani NE, Hashtroudi AA, Sayah A, Pursamimi P, Bashashati M, Shakiba M. Severity of progression of liver disease in chronic hepatitis C: role of smoking. Indian J Gastroenterol 2006;25:167-8. (Pubitemid 44326065)
11. Di Costanzo GG, De Luca M, Tritto G, Lampasi F, Addario L, Lanza AG et al. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis. Eur J Gastroenterol Hepatol 2008;20:674-9.
12. Yuen ST, Gogo AR Jr, Luk IS, Cho CH, Ho JC, Loh TT. The effect of nicotine and its interaction with carbon tetrachloride in the rat liver. Pharmacol Toxicol 1995;77:225-30.
13. Baskaran S, Lakshmi S, Prasad PR. Effect of cigarette smoke on lipid peroxidation and antioxidant enzymes in albino rat. Indian J Exp Biol 1999;37:1196-200. (Pubitemid 30041955)
14. Mori Y, Koide A, Kobayashi Y, Furukawa F, Hirose M, Nishikawa A. Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver. Mutagenesis 2003;18:87-93. (Pubitemid 36113611)
15. Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG. Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2006;4:797-801. (Pubitemid 43825810)